Correlation Between Antisense Therapeutics and Alterola Biotech
Can any of the company-specific risk be diversified away by investing in both Antisense Therapeutics and Alterola Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antisense Therapeutics and Alterola Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Antisense Therapeutics Limited and Alterola Biotech, you can compare the effects of market volatilities on Antisense Therapeutics and Alterola Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antisense Therapeutics with a short position of Alterola Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antisense Therapeutics and Alterola Biotech.
Diversification Opportunities for Antisense Therapeutics and Alterola Biotech
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Antisense and Alterola is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Antisense Therapeutics Limited and Alterola Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alterola Biotech and Antisense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antisense Therapeutics Limited are associated (or correlated) with Alterola Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alterola Biotech has no effect on the direction of Antisense Therapeutics i.e., Antisense Therapeutics and Alterola Biotech go up and down completely randomly.
Pair Corralation between Antisense Therapeutics and Alterola Biotech
Assuming the 90 days horizon Antisense Therapeutics is expected to generate 2.51 times less return on investment than Alterola Biotech. But when comparing it to its historical volatility, Antisense Therapeutics Limited is 1.47 times less risky than Alterola Biotech. It trades about 0.03 of its potential returns per unit of risk. Alterola Biotech is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 5.20 in Alterola Biotech on October 23, 2024 and sell it today you would lose (4.90) from holding Alterola Biotech or give up 94.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 96.98% |
| Values | Daily Returns |
Antisense Therapeutics Limited vs. Alterola Biotech
Performance |
| Timeline |
| Antisense Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Alterola Biotech |
Antisense Therapeutics and Alterola Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Antisense Therapeutics and Alterola Biotech
The main advantage of trading using opposite Antisense Therapeutics and Alterola Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antisense Therapeutics position performs unexpectedly, Alterola Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alterola Biotech will offset losses from the drop in Alterola Biotech's long position.| Antisense Therapeutics vs. Amexdrug | Antisense Therapeutics vs. Aion Therapeutic | Antisense Therapeutics vs. Alterola Biotech | Antisense Therapeutics vs. The BC Bud |
| Alterola Biotech vs. Amexdrug | Alterola Biotech vs. Aion Therapeutic | Alterola Biotech vs. The BC Bud | Alterola Biotech vs. Crescita Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |